AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract HHSO100201700020CREGENERON PHARMACEUTICALS, INC.
Overview
Award facts
- Net obligations
- $278.84M
- $278,844,172of $359.61M potential value
- Outlays (paid to date)
- $236.33M
- $236.33M paid of $278.84M obligated$236,330,037
- Period of performance
- Sep 21, 2017 to Sep 25, 2027
- Ends in 10 months
- Modifications
- 17
- Latest action Sep 16, 2026
- Contract type
- Definitive contract
- PIID HHSO100201700020C
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
Dates and value
- Award date
- Signed on Sep 21, 2017
- Current value
- $278,844,172Base and exercised options
- Potential value (if all options are exercised)
- $359,611,758
Obligations by fiscal year of action
- FY2026: -$766,396 (de-obligation)
- FY2025: -$331,708,160 (de-obligation)
- FY2023: $326,475,498
- FY2020: $246,597,124
- FY2019: $19,552,893
- FY2017: $18,693,213
Total across 6 fiscal years: $278,844,172
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 16, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationTARRYTOWN, NY
UEIN3F9MH7E6HD6
CAGE code544P9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyREGENERON PHARMACEUTICALS INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Administration For Strategic Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Administration For Strategic Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Tarrytown, Westchester County, New York 10591-6717
- Congressional district (place of performance)
- NY-17As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost sharingT
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- BAA16100SOL00002(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Novel antibodies against influenza virus, emerging, re-emerging, and pre-emerging pathogens
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 21, 2017Base obligation at award: $18,693,213
- Latest action
- Sep 16, 2026 — Supplemental agreement (within scope)Modification P00017; obligation change -$766,396
- Latest substantive action
- Sep 16, 2026 — Supplemental agreement (within scope)Modification P00017; obligation change -$766,396
- Latest funding action
- Apr 29, 2020 — Funding onlyModification P00007; obligation change +$9,247,916; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action7
- Supplemental agreement (within scope)5
- Change order4
- Funding only1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$766,396
- Latest action: change in base and all options
- -$766,396
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 18
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2019/2020-0140-000
- 075-2020/2021-0140-000
- 075-2020/2024-0140-000
- 075-X-0140-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- N: Emergency P.L. 116-136
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $142,753,157
- COVID-19 supplemental outlays
- $228,763,508